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Abstract
Olfactory receptors (ORs), which are involved in odorant recognition, form the largest mammalian protein superfamily. The
genomiccontentof ORgenesisconsiderablyreducedin humans,asreflectedbytherelativelysmall repertoiresizeandthehigh
fraction (,55%) of human pseudogenes. Since several recent low-resolution surveys suggested that OR genomic loci are
frequently affected by copy-number variants (CNVs), we hypothesized that CNVs may play an important role in the evolution of
the human olfactory repertoire. We used high-resolution oligonucleotide tiling microarrays to detect CNVs across 851 OR gene
and pseudogene loci. Examining genomic DNA from 25 individuals with ancestry from three populations, we identified 93 OR
gene loci and 151 pseudogene loci affected by CNVs, generating a mosaic of OR dosages across persons. Our data suggest that
,50% of the CNVs involve more than one OR, with the largest CNV spanning 11 loci. In contrast to earlier reports, we observe
that CNVs are more frequent among OR pseudogenes than among intact genes, presumably due to both selective constraints
and CNV formation biases. Furthermore, our results show an enrichment of CNVs among ORs with a close human paralog or
lacking a one-to-one ortholog in chimpanzee. Interestingly, among the latter we observed an enrichment in CNV losses over
gains, a finding potentially related to the known diminution of the human OR repertoire. Quantitative PCR experiments
performed for 122 sampled ORs agreed well with the microarray results and uncovered 23 additional CNVs. Importantly, these
experimentsallowedus touncover ninecommondeletionallelesthataffect15ORgenesand five pseudogenes.Comparisonto
the chimpanzee reference genome revealed that all of the deletion alleles are human derived, therefore indicating a profound
effect of human-specific deletions on the individual OR gene content. Furthermore, these deletion alleles may be used in future
genetic association studies of olfactory inter-individual differences.
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Introduction
Olfaction, the sense of smell, is characterized by the remarkable
ability to detect and discriminate millions of odorous compounds.
It contributes significantly to our perception of the environment
and to our quality of life [1]. At the molecular level, olfaction is
mediated by a conserved signal transduction cascade, which is
initiated by the binding of odorants to specific G-protein coupled
receptors, known as olfactory receptors (ORs) [2,3]. The human
OR repertoire is comprised of 851 genes and pseudogenes,
organized in clusters on almost every chromosome [4]. During
human evolution these gene clusters underwent dynamic processes
of expansion, diversification and duplication as well as diminution
and pseudogenization [5], processes which may be still ongoing.
Since members of the human species depend on their sense of
smell to a lesser degree than other mammals, their OR repertoire
has undergone an accelerated process of pseudogenization,
resulting in functional inactivation of more than 50% of the
ORs by frame-disrupting mutations. Furthermore, the lower
degree of purifying selection in human olfaction also appears to
result in enhanced inter-individual genome diversity, e.g. the
prevalence of high-frequency inactivating single nucleotide
polymorphisms (SNPs), i.e. segregating pseudogenes [6]. Thus,
the human OR repertoire serves as an interesting model for
genome evolution and variability.
Human olfactory perception exhibits considerable phenotypic
variation, for which a genetic basis has been proposed [7–10].
Recently two studies associated common SNPs affecting OR genes
OR7D4 and OR11H7P to human sensitivity and perception of the
respective odorants androstenone and isovaleric acid [11,12].
These findings support a relationship between genotypic and
phenotypic variability in human olfaction.
However, recent results indicate that most of the variation in the
human genome is not accounted for by SNPs. Genome structural
variants, usually defined as kilobase (kb) to megabase (Mb) deletions,
duplications, insertions, and inversions, emerge as responsible for the
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be a main basis for phenotypic differences [16]. Structural variants
affecting the copy-number of a $1 kb genomic region (e.g. through
deletion or duplication) are widely referred to as Copy Number
Variants (CNVs; [17]). Several genome wide surveys have recently
reported a prevalence of OR genes among CNVs [13,14,18,19],
suggesting an impact of CNVs on the individual OR gene content.
Moreover, recent reviews have suggested that CNVs have an impact
on the genome in longer evolutionary terms by facilitating the
expansion or diminution of gene families [20,21]. However, these
genome-wide surveys did not focus on ORs specifically, and were
either carried out at low-resolution, suitable for genomic clusters of
ORs rather than for single OR loci, or considered few (i.e., 8)
individuals. A gene-level resolution survey of copy-number variabil-
ity in the largest mammalian gene superfamily should thus serve as
an excellent model for studying long-term effects of CNVs on the
genome. Furthermore, such a survey may help identifying
candidates for examining potential phenotypic consequences of
CNVs on smell perception.
Here, we report a high-resolution analysis of CNVs affecting the
human OR repertoire. We use custom high-resolution oligonucle-
otide tiling microarrays to study OR gene copy-number variation in
25 individuals with ancestry in three human populations, and report
thataboutafourthofallOR genesarecommonlyaffectedbyCNVs.
In addition, we find that CNVs affecting ORs are more complex
than previously appreciated. Furthermore, evolutionarily ‘‘young’’
ORs, as well as OR pseudogenes, show a strong tendency for copy-
number variation. In addition, using confirmatory quantitative PCR
(qPCR), we report a total of 15 OR gene loci with an appreciable
prevalence of homozygous deletion genotypes in humans. These
deletionsmayprovideanadditional,CNV-based,genotypicbasisfor
variations in human olfactory perception.
Results
A High-Resolution Map of CNVs Affecting OR Genes and
Pseudogenes
Analyzing the microarray results we identified OR loci with
median normalized microarray log2-intensity ratios R that
significantly deviated from expected measures, and were thus
scored as CNVs (see Methods). Altogether, we observed 1301
CNV events (gains and losses) affecting loci harboring intact OR
genes and pseudogenes in the 25 individuals analyzed (Figure 1A).
Notably, due to the comparative nature of our analysis, this results
in 24, rather than 25, sets of CNVs. Of the 851 OR loci
interrogated, 244 ORs (28%, including 93 intact genes and 151
pseudogenes) were observed to be affected by CNVs (Tables 1,
S1). Next, we examined to what extent CNVs affect the individual
genomic OR content. On average, we observed CNV events in 22
OR genes and 32 OR pseudogenes per sample (mean number of
CNV events per sample; see Methods). The vast majority of these
probably represent true positives, as we generally estimate a false-
positive rate of less than 4% for CNV assignments based on a
control (self-vs.-self hybridization; see Methods). Interestingly,
meta-analysis of lower resolution data performed by Nozawa et
al. [19] indicated a mean difference of only 10.9 intact OR genes
and 11.3 OR pseudogenes between individuals. Our considerably
higher numbers are presumably explained by the fact that many
CNVs detected in our study are below the resolution of the CNV-
detection methods that were available to Nozawa et al. (see e.g.
discussions in recent studies using high-resolution mapping
approaches [14,15,29]).
A more detailed view of the microarray results was generated
for two subsets of the OR repertoire. One (Figure 1B, left panel)
encompasses the OR gene subset for which qPCR has been
performed. The second, an even stronger, zoom view is afforded
by the left panel of Figure 1C, where the most variable 25 loci,
with 56 OR genes, are shown. Both views highlight the fact that
CNVs create unique mosaics of OR dosages across individuals
that might contribute to the functional individuality of the human
nose. Furthermore, the qPCR results led us to detect 23 additional
CNVs that were not detected by the microarrays and were added
to our map. Fifteen of these intersect with CNVs reported in the
Database of Genomic Variants (DGV; http://projects.tcag.ca/
variation/; see Table 2), which corroborates our qPCR results.
Such a false-negative rate was not unexpected for the array-based
CNV-calls, since microarrays have been reported to miss some
true-positive CNVs [13–14].
The high resolution of our approach also allowed us to more
precisely predict the location of CNV breakpoints from micro-
arrays. To this end we used the microarray-data based BreakPtr
algorithm [23] to identify instances where the breakpoints of
CNVs are located within an OR locus (see Methods). Disrupted/
split loci were detected for 88 ORs, suggesting a surprising
complexity of CNV genotypes (Table S3). For eight of these loci
our data suggest recurrent CNV formation events, since for
different samples distinct breakpoint locations were predicted
(Table S3). While most CNV breakpoints do not disrupt the
,900 bp OR coding regions, the BreakPtr algorithm predicts
disruption of coding regions of four specific OR loci (OR4C16,
OR1M1, OR6B2, and OR4N2; see Table S3). Although further
experiments will be necessary to validate these predicted coding
region disruptions, additional sequence analyses described below
indicate that OR coding sequence may be directly involved in
CNV formation, e.g. leading to novel OR fusion genes.
Validation of Identified CNVs
We used three different methods for CNV validation, i.e. (i)
comparing our CNV-calls to previously reported CNVs from DGV
[30], (ii) performing quantitative PCR (qPCR), and (iii) performing
conventional PCR. Initially, when comparing our results to DGV,
we found that in total, 134 (55%) copy-number variable OR loci
intersected with previously described CNVs (Table 1). Our capacity
Author Summary
Copy-number variants (CNVs) are deletions and duplications
of DNA segments, responsible for most of the genome
variation in mammals. To help elucidate the impact of CNVs
onevolution andfunction, weprovide a high-resolutionCNV
map of the largest gene superfamily in humans, i.e., the
olfactory receptor (OR) gene superfamily. Our map reveals
twice as many olfactory CNVs per person than previously
reported, indicating considerable OR dosage variations in
humans. In particular, our findings indicate that CNVs are
specificallyenriched among evolutionary ‘‘young’’ ORs,some
of which originated following the human-chimpanzee split,
implying that CNVs may play an important role in the gene-
birth and gene-loss processes that continuously shape the
human OR repertoire. Furthermore, we describe 15 OR gene
loci showing frequent human-specific deletion alleles.
Additionally, we present evidence for a recent non-allelic
homologous recombination event involving a pair of OR
genes, forming a novel fusion OR that may harbor novel
odorant-binding properties. Such events may potentially
relate to individual functional ‘‘holes’’ in the human smell-
detection repertoire, and future studies will address the
specific chemosensory impact of ourgenomic variation map.
Olfactory Receptor CNVs
PLoS Genetics | www.plosgenetics.org 2 November 2008 | Volume 4 | Issue 11 | e1000249Figure 1. A high-resolution map of CNVs in the human OR repertoire. A) CNV map for OR loci based on high-resolution oligonucleotide
tiling arrays. 851 ORs are ordered according to their location along the chromosomes, as indicated on the left; rows represent genes, columns are
individuals; gains are shown in red, losses in blue and un-changed dosage in green (calls were made relative to the male reference individual
NA19154). Note that the non-uniform genomic distribution of ORs results in an unbalanced representation of chromosomes in panel A. Also, note
that ‘gains’ on chromosome X do not represent CNVs but refer to the expected male/female dosage difference. CNV calls are given for all 25
Olfactory Receptor CNVs
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relatively few individuals were examined when compared to the
multiple studies contributing to DGV, stresses the sensitivity and
overall value of our high-resolution CNV map.
Subsequently, we validated CNVs by performing qPCR on 122
OR loci (104 ORgenes and 18 pseudogenes), which were selected to
represent both high and low variability loci (Figure 2, S2) and which
included similar amounts of novel and already known CNVs. Sixty
validation experiments were carried out with a panel of only 13
samples, while the other 62 experiments were performed in 23
samples. We initially compared individual microarray intensities
(normalized log2-intensityratios)toqPCRoutcomes(normalized Cp-
values). In general, qPCR results revealed an acceptable correlation
to the normalized microarray values (Figure S3A, S3B), with the
exception of a small group of 23 OR loci that displayed considerable
qPCR inter-subject variability despite low-variability microarray
values(FigureS3A,S3B).Weaddedthese23casestoourlistofcopy-
number variable OR loci (Table 2; Figure S4).
Next, we examined the rate at which CNV calls were validated
by qPCR (qPCR results were therefore normalized relative to
reference individual NA19154): 87% of all CNVs tested yielded
negatively correlating Cp-values, as expected, indicating successful
validation, with similar success rates for gains and losses. In the
majority of cases, rounded absolute qPCR-measures were equal to
Cp=1, in line with an abundance of simple gains and losses (i.e.
heterozygous deletions and duplications). Taken together, most
CNV calls can be validated by qPCR, demonstrating a very
reasonable specificity of our platform.
Finally, for two cases (deletions I and II, Table 3), we validated
qPCR results that indicated homozygous deletions, i.e. such that
consistently failed in specific DNA samples, by conventional PCR
with an additional set of primers (Figure S5). For both deletion
alleles, two positive and two negative samples were tested.
Standard PCR confirmed our results in both cases, validating
Table 1. Summary of array results for OR gene and
pseudogene loci and comparison with DGV.
Intact Pseudogenes Total
# Genes in array 385 466 851
# Genes that show gains 68 122 190
# Genes that show losses 53 82 135
# Variable genes 93 (24%) 151 (32%) 244 (28%)
# Genes in
New CNVs 42 68 110
Confirmed CNVs 51 83 134
Undetected CNVs 106 118 224
Confirmed not-variable 188 195 383
Copy-number variable loci are OR loci with R–measures (median normalized
microarray intensity log2-ratio across an OR locus) falling beyond the cutoff
C=|0.18| (see Methods). ORs were considered as copy-number variable if a gain
or loss was identified in at least one individual. The variability status of each
locus was compared to the Database of Genomic Variants (DGV). ‘‘New CNV’’:
CNV identified by us, not in DGV; ‘‘Confirmed CNV’’: CNV identified by us,
present in DGV; ‘‘Undetected CNV’’: present in DGV, not identified in our panel
of individuals; ‘‘Confirmed not variable’’: was not identified as being copy-
number variable by us, and is not reported in DGV.
doi:10.1371/journal.pgen.1000249.t001
Table 2. CNVs detected in qPCR experiments that displayed
little variability in microarray experiments.
OR locus qPCR-variance variance of R Status in DGV
OR10AG1 0.693519007 0.002244359 CNV
OR10J3 0.227390436 0.000961263 NR
OR10J5 0.22072615 0.00106244 NR
OR10Z1 0.573520272 0.001973186 NR
OR1A2 0.176006731 0.000929803 CNV
OR1G1 0.418577965 0.002270532 CNV
OR2AJ1 0.414815785 0.002147011 CNV
OR2B11 0.396684535 0.005136635 CNV
OR2G3 0.396707452 0.001385149 CNV
OR2L13 0.511584535 0.002920064 CNV
OR2T29 0.150669223 0.003118704 CNV
OR2T6 0.61481576 0.000332848 CNV
OR4A45P 0.226808226 0.003287325 CNV
OR4C13 0.494025825 0.002679713 CNV
OR4E2 0.387122516 0.001315008 CNV
OR4K14 0.162403526 0.001719849 CNV
OR5AK2 0.261028206 0.003661852 NR
OR6C2 0.410398478 0.003290131 CNV
OR6C4 0.193139103 0.001050314 CNV
OR6K2 0.173307692 0.002568683 NR
OR6Q1 0.240047903 0.002727374 NR
OR6Y1 0.162319311 0.002412609 NR
OR9G1 0.295386696 0.001038619 NR
Twenty-three ORs were found to be variable in qPCR experiments (beyond a
conservative cutoff for the variance of .0.15), but not in the microarrays. NR:
not previously reported.
doi:10.1371/journal.pgen.1000249.t002
individuals (i.e. a self-vs.-self-replicate of NA19154 was included as a control; see Methods). Due to the resolution of the figure single CNVs may not be
visible (all events are given in Table S2). Samples appear in the following order (1–25); NA10851, NA11997, NA12003, NA12004, NA12005, NA12006,
NA12246, NA12248, NA12865, NA15510, NA18501, NA18502, NA18504, NA18505, NA18506, NA18508, NA18611, NA18856, NA18945, NA18946,
NA18972, NA19103, NA19128, NA19141, NA19154. B) qPCR and microarray measurements of 122 OR loci for 13 individuals. The right panel represents
qPCR results, and the left panel the corresponding microarray measurements (i.e. the measure R; see Methods). Sixty of the 122 ORs were tested in 13
individuals, thus only data for these samples is shown (for the full dataset, see Table S1). OR loci were sorted based on copy-number variability as
assessed with our microarrays; the top 40 rows represent genes categorized as CNVs by microarrays; the lower part refers to loci not scored as a CNVs
with the arrays, but scored as CNVs by qPCR (see Table 2). qPCR data was normalized relative to NA19154, and inverted (values multiplied with 21) to
fit to the microarray scale. OR2BH1P and OR9G1 showed homozygous deletion in the reference individual, thus the qPCR values of these ORs were not
normalized. Relative intensities are color coded, as indicated by the color scales. Homozygously deleted OR alleles are shown in the right panel in
black. Samples appear in the following order; NA12003, NA12004, NA12005, NA12006, NA12246, NA12248, NA12865, NA18504, NA18508, NA18856,
NA19103, NA19141, NA19154. C) qPCR-measurements and array (R) measures for the 56 most variable OR loci. The most variable OR loci were
selected based on variance in qPCR results. Representation and sample order is as in panel B.
doi:10.1371/journal.pgen.1000249.g001
Olfactory Receptor CNVs
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and homozygous deletion II in NA19103 and NA19141.
Genomic Distribution of CNVs
CNVs affecting OR loci are strongly non-uniformly distributed,
causing a clustering of CNVs into ‘hotspots’, and an associated
clustering of regions with high variance in normalized microarray
intensities (see Figures 1A, 2). Accordingly, there is a strong
correlation (0.8, P-value=10
218) between the variance (based on
measure R) of a variable OR to the variance of adjacently located
ORs (Figure S6A). Some of the clustering can be explained with
an enrichment of CNVs near telomeres and centromeres (Figure
S6B), consistent with observations from a previous report [13].
Genomic CNV formation biases are a plausible explanation for
the clustering. Furthermore, CNV size (e.g. CNVs affecting
multiple ORs) and biases in evolutionary selection are likely also
responsible for the observed non-uniform distribution in our data
(see below).
We analyzed apparent CNV ‘hotspots’ in more detail, and
observed that the 244 variable OR loci were clustered into 149
extended genomic blocks displaying a common pattern of
variability (Figure S7). To examine whether observed blocks of
high copy-number variability actually behave as single (large)
CNVs we performed an analysis addressing the correlation of
cross-individual patterns within each of these blocks (Figure S6C).
Indeed, the analysis identified 31 copy-number blocks containing
105 OR loci with a Pearson correlation coefficient .0.8 in cross-
individual normalized microarray measures R, indicating that the
blocks likely correspond to a single, large CNV. The largest such
block is located on chromosome 14 and contains 11 OR loci. On
the other hand, this suggests that many of the remaining candidate
hotspots may underlie several independent (i.e. smaller) CNVs
occurring in close proximity. However, although large CNVs (such
that span more than one OR locus) are relatively rare (involving
43 out of OR 149 loci only), they contribute to our inter-individual
variability to approximately the same extent as small CNVs.
Moreover, the multi-locus CNVs are important from a functional
aspect, as large CNVs that affect several ORs simultaneously are
more likely to result in detectable phenotypes than small ones.
Evolutionary Selection and Formation Bias as
Contributors to Copy-Number Variation in the OR
Repertoire
Our high-resolution map of CNVs affecting OR genes further
enabled us to address questions relating to the evolution of the OR
repertoire. We first tested whether the evolutionary age of an OR
gene is correlated with its propensity to be affected by a CNV.
Interestingly, we found that ORs with a closely related paralog in
the human genome, evaluated using the level of sequence identity
as a measure, are significantly more likely to be affected by CNVs
than ORs lacking a closely related paralog (Figure 3). In other
words, evolutionarily ‘‘younger’’ ORs tend to be more frequently
affected by CNVs than more ‘‘ancient’’ ORs. To confirm this
trend using a different approach to classify OR genes into ‘‘young’’
and ‘‘ancient’’ we used one-to-one orthology relationships with the
chimpanzee genome and categorized OR genes into ‘‘young’’ if
they lacked a one-to-one ortholog and ‘‘ancient’’ in the case of
unambiguous orthology: indeed, we found that OR genes that
recently exhibited a duplication/loss event in the human, or the
chimpanzee genome (i.e. such genes lacking one-to-one orthologs
between human and chimp), are significantly more likely to be
affected by CNVs than OR genes with unambiguous one-to-one
orthologs (Pvalue,0.001, Figure 4A). We note that these findings
are compatible with a suggested general model of copy-number
variation as an evolutionary basis of paralog birth [20,21],
whereby novel paralogs, manifested as CNVs, may later become
fixed in the population.
We further note that the enrichment of CNVs in ‘‘younger’’ OR
genes may be due to two reasons: First, the higher number of
CNVs observed in ’’younger’’ ORs may be due to decreased
selective pressures in ‘‘young’’ ORs compared to ‘‘ancient’’ ORs
(see below). Second, different CNV formation biases acting on
genomic regions harboring ‘‘young’’ and ‘‘ancient’’ ORs may be
responsible. We first evaluated the impact of CNV formation bias
through testing whether pairs of tandemly oriented segmental
duplications (SDs; [31]) – known mediators of CNV de novo
formation through induction of non-allelic homologous recombi-
nation (NAHR) – are enriched among the ORs affected by CNVs.
When performed at single gene resolution, this analysis yielded
Figure 2. Copy-number variability expressed as variance of experimental measures. Variance in array measurements is indicated along OR
loci, with loci arranged according to genomic coordinates. The variance of individual array measurements for each OR is plotted in grey. Array
variance of ORs that were assayed by qPCR is color-coded; green: OR genes; red: OR pseudogenes. Black squares indicate ORs listed in Table 3;
representative ORs from each cluster are indicated by red doted lines.
doi:10.1371/journal.pgen.1000249.g002
Olfactory Receptor CNVs
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bias caused by the fact that neighboring OR loci are often located
in close vicinity in the genome, forming genomic clusters (see Text
S1). We thus examined the potential impact of NAHR also at the
level of 135 genomic clusters of OR loci, which are listed in the
HORDE database (http://bioportal.weizmann.ac.il/HORDE/
index.html), and observed a significant and robust enrichment
(with P-values,0.01) of SD-pairs among highly copy-number
variable clusters compared to clusters for which no single CNV has
been observed in our study (see Text S1 for details and Figure S8).
Thus, our data indicate that NAHR has likely biased the
distribution of CNVs within the OR repertoire.
Next, we tested whether, and to what extent, evolutionary selection
may influence CNVs affecting the OR repertoire. In this regard, we
first revisited the recent report that OR pseudogenes areequallylikely
to be affected by CNVs as OR genes, a finding suggesting a neutral
evolution of OR copy number variation [19]. In particular, we
compared CNVs in OR genes and pseudogenes, and found that OR
pseudogenesaresignificantlymorelikelytobeaffectedbyCNVsthan
OR genes (Table 1, Pvalue=0.007, x
2 statistic=7.38, DF=1). A
consistent and significant signal was also observed when carrying out
the analysis at the level of microarray probes, either only for the
coding regions or for the adjacent non-coding regions (see
supplementary Text S1). This may indicate that stronger evolution-
ary constraints act on OR genes than on pseudogenes. Additionally,
we analyzed the frequency of CNVs among OR genes and
pseudogenes separately for the ‘‘young’’ and ‘‘ancient’’ ORs
(Figure 4B). This analysis showed that the difference between
‘‘young’’ and ‘‘ancient’’ ORs is greater than the difference between
OR genes and pseudogenes. Nonetheless, in both groups OR genes
were less prone to CNV formation than pseudogenes, indicating a
mixed contribution of formation bias and selection (see below).
Having established that ‘‘young’’ ORs are more prone to CNVs
than the ‘‘ancient’’ ones, we further addressed which types of
CNVs, i.e. gains or losses, are most common in the two OR
groups. Interestingly, for both ‘‘ancient’’ and ‘‘young’’ ORs we
observed significant imbalances between gains and losses
(Figure 5A, Pvalue=0.006, x
2 statistic=10.3, DF=2 and Pvalue=0,
x
2 statistic=43.8, DF=2, respectively). Notably, the two groups
exhibited an opposite over-all trend, i.e. ‘‘ancient’’ ORs displayed
significantly more gains than losses and ‘‘young’’ ORs showed
significantly more losses than gains. As we arbitrarily picked a
reference individual in our study, we also tested whether the
observed trend was robust if neglecting the reference, by looking
for ORs that exhibited only one type of CNV – gain or loss – in at
least 50% of the samples (Text S1 material). Although this analysis
revealed that some of the reported events are likely attributable to
rare alleles in the reference individual, the trend of opposite
balances between gains and losses in the two groups remained
significant (Pvalue=0.004, x
2 statistic=11.1, DF=2).
Potential Functional Impact of CNVs Affecting OR Genes
CNVs affecting OR loci may encompass deletions, duplications
or more complex allelic structures. In this realm, homozygosity for
deletion alleles is the CNV-related genotype that is most likely to
cause a direct olfactory phenotypic effect. This is because, with
some exceptions, OR gene disruption is likely to be recessive, i.e.
only absence of the functional gene product will result in an
observable phenotype. In particular, a dosage effect stemming
from a different number of active OR copies is not expected due to
clonal exclusion, whereby only one paralog is expressed in any
given sensory neuron [32,33]. Thus, we particularly focused on the
identification of frequent deletion alleles, which may lead to
common differences in smell perception between individuals.
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PLoS Genetics | www.plosgenetics.org 6 November 2008 | Volume 4 | Issue 11 | e1000249While carrying out qPCR-based validation experiments, for
several OR loci we immediately identified samples that consis-
tently failed to amplify during qPCR, suggesting a potential
homozygous deletion of the OR locus (Table 3). For example, two
samples (NA12003 and NA12246) consistently failed to amplify
neighboring ORs from a specific locus on chromosome 11 (Figure
S5). In particular, this variation was found to harbor a genomic
region of 82 kb involving 4 OR genes and 2 OR pseudogenes.
The distribution of median normalized microarray intensity log2-
ratios (measure R) of OR loci in this region (Figure 5) is consistent
with a bi-allelic CNV and with dosage levels corresponding to 0, 1,
or 2 copies. Furthermore, PCR with uniquely designed primers for
ORs in that region yielded no product for NA12003 and
NA12246 and bands of expected size in positive controls
(NA12004 and NA19141), thus supporting both the microarray
and the qPCR results (Figure S5).
We note that a subset of common OR deletions may not be
tractable with the approach presented here, as they were deleted
from the individual(s) contributing to the human reference
genome, which we used to design our high-resolution arrays.
Thus, to identify additional potential deletions affecting OR genes,
we further searched for discrepancies between the human genome
Figure 4. CNVs preferentially affect ORs lacking unambiguous one-to-one orthologs in the chimpanzee genome. A) Gains and losses
of OR loci were called using our microarrays (see Methods). Gains are shown in blue; losses in orange; n is the number of total calls considered (24
samples multiplied by the number of genes in each category). OR loci with a one-to-one (‘‘1-2-1’’) ortholog in the chimpanzee genome are
significantly (Pvalue,0.001; Mann-Whitney U test) less often affected by CNVs than loci lacking a 1-2-1 ortholog. B) Frequencies of CNV loci are given
separately for intact OR genes and pseudogenes in each of the evolutionary classes. ‘‘Frequency’’: relative frequency of being called a CNV for a set.
doi:10.1371/journal.pgen.1000249.g004
Figure 3. Correlation of OR copy-number variability with paralog-similarity. Red and blue dots indicate copy-number variable and non-
variable ORs, respectively (copy-number variability is expressed in terms of the measure R, see Methods, which we found to correlate well with gene
dosage). Percentage DNA sequence identity (‘‘% identity’’) to the closest paralog in the human genome is plotted versus the array-based (i.e., R-
measure-based) variance. Correlation for ORs affected by CNVs is C=0.26 (Pvalue=10
25), whereas for non-variable ORs it is C=0.15 (Pvalue=10
24).
Linear regression fits for each dataset are indicated with red and blue dashed lines, respectively.
doi:10.1371/journal.pgen.1000249.g003
Olfactory Receptor CNVs
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In particular, we searched for OR genes that reside in regions of
disagreement between the reference genome and publicly
available data from the initial Celera human genome assembly
[34], Craig Venter’s genome [28], James Watson’s genome [35],
and fosmid clones which are not part of the current reference
assembly. Altogether,weidentified three OR genes, OR8U8,OR8U9
and OR9G9,which arenotpresentinthecurrent referenceassembly.
The first two present an interesting case, whereby two intact OR
genes (OR8U8 and OR8U9) appear to have recently fused through
NAHR, which led to the formation of a chimeric OR gene (OR8U1;
Figure S9). Moreover, sequence comparison between OR8U8,
OR8U9,a n dOR8U1 identified a plausible NAHR recombination
region, i.e. a 119 bp interval (bp 472–590 in Figure S9), which
displays 100% DNA sequence identity between the three genes.
qPCR with allele specific primers, designed at the interface of the
recombination region, identified 4 individuals heterozygous for the
deletion (Table 3). A similar case, where the recombination between
OR51A2 and OR51A4 results in a new gene encoding an amino acid
sequence identical to OR51A4 and upstream regions from the
OR51A2 gene was reported previously [14]. Together, these
observations indicate that ORs themselves, rather than their
genomic environment, may frequently promote CNV formation
through NAHR. In the third case, OR9G9,a l t h o u g ha b s e n tf r o mt h e
reference genome, was identified in all individuals tested by qPCR.
However,itsclosestparalog–OR9G1washomozygouslydeletedin3
out of 23 individuals tested.
Altogether, fosmids and the individual genomes of Craig Venter
and James Watson supplied additional support for 3 deletion loci
(deletions I,II and VI; Table 3) identified by qPCR (Table 3). We
further followed up 9 regions, encompassing 15 OR genes, for which
deletion alleles were initially identified by qPCR. For 8 out of the 9
deletionsweestimateddeletionallelefrequenciesfromthenumberof
homozygouslydeletedindividuals inourcohort at approximately0.2
up to 0.6 (Table 3). Notably, deletion VII appears only in the Yoruban
individuals, which may suggest population-specificity of this allele.
Yet, this bias should be interpreted with caution, as the number of
samples we employed from each population is insufficient for
meaningful comparison between the populations.
Examination of the chimpanzee reference genome (see Methods)
shows that all deletions identified in this study are likely to represent
human derived alleles (Table 3), barring presumably infrequent
shared polymorphisms. A recent survey [15] on genomic structural
variation in different individuals, which identified deletions with an
initial resolution in breakpoint assignment of 20–40 kb (and base-
pair resolution for several cases in which breakpoint junctions were
sequenced), reported variants that are consistent with all deletion
allelesreportedinourstudy.Thisvalidatesourfindingsand confirms
the frequent occurrence of these variants; thus, a considerable
number of OR genes are frequently deleted in humans, with
homozygous alleles occurring commonly in the population.
Discussion
We have carried out a high-resolution analysis of CNVs
affecting OR gene and pseudogene loci, and identified many OR-
related CNVs for which copy-number variability has not been
reported previously. In contrast to a previous low-resolution study
[19] we observe that CNVs are enriched among evolutionary
young ORs as well as pseudogenes. Our results differ from those
published by Nozawa et al., probably due to the significant
increase in resolution (nearly 2 orders of magnitude, from 50–
100 kb to ,1 kb), which enabled us to focus on single loci, rather
than clusters, and thus to distinguish unaffected OR genes (non-
CNVs) from adjacently located affected OR pseudogenes (CNVs).
Our analysis suggests that both formation bias and evolutionary
constraints have likely shaped the distribution of CNVs in the
human OR repertoire. In fact, both biases are difficult to
distinguish. For instance, pseudogenes and other repeats are
known to be enriched in vertebrate gene deserts [36], which is
presumably both due to mutational and selective biases. Also, we
defined OR pseudogenes based on the absence of an intact open
Figure 5. Zoom into a bi-allelic CNV affecting OR4C11. Plot depicting median normalized log2-ratios of microarray intensities for OR loci
affected by deletion I (chr11: 55127497–55238834), a bi-allelic CNV. Each individual is color-coded as indicated in the legend shown to the right. Black
arrows indicate samples that consistently failed to produce results in the qPCR and standard PCR assays, indicating a potential homozygous deletion.
doi:10.1371/journal.pgen.1000249.g005
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misclassification of some of the intact genes, which may not be
functional in reality, due to missense mutations [37] or mutations
affecting non-coding regulatory elements. However, both of these
confounding factors are presumably affecting only a minority of
loci and thus are unlikely to influence our conclusions in relation to
a depletion of CNVs affecting OR genes relative to OR
pseudogenes.
Furthermore, our data showed a bias for CNV-enriched OR
loci to be located between tandemly oriented segmental duplica-
tions, which are known to induce NAHR [38]. Besides NAHR,
other formation-processes such as non-homologous end-joining
(NHEJ; [39]) are likely to play a role in the genesis of CNVs
affecting OR loci. In the future, determining the relative
contribution of such mutational processes will require the
identification of the breakpoint junction sequences of numerous
CNVs. In addition to regional biases caused by different
mutational processes involved in CNV formation, large CNVs
may sometimes span both genes and adjacently located unpro-
cessed pseudogenes. Unprocessed pseudogenes often arise through
tandem duplication of OR loci followed by inactivation of the
newly generated, neutrally evolving, paralogous loci. This may
lead to biases in the frequency at which pseudogenes vary in terms
of copy-number, depending on selective constraints acting on
adjacent functional loci. Finally, even in the absence of large
CNVs such a bias may occur, as CNVs affecting pseudogenes in
the proximity of genes may be detrimental due to long-range
regulatory effects (e.g., through interfering with non-coding
regulatory elements). Furthermore, the enrichment of CNVs
among ORs located in close proximity to telomeres/centromeres
may also be reflective of CNV formation biases or selective biases.
In this regard, human subtelomeric regions are enriched for
segmental duplications, and NHEJ and NAHR presumably
operate efficiently in those regions [39]. At least for some cases,
we were already able to present sequence-based evidence for the
likely involvement of NAHR in CNV formation. In particular, we
demonstrated that CNVs causing a fusion of tandemly oriented
OR genes were presumably formed through NAHR (Figure S9
and [14]). Such events exemplify a potential mechanism for
accelerated functional diversification of ORs, where paralogs are
originally created with new function or regulation pattern, rather
than through the process of sequential duplication and diversion.
Consequently it may be hypothesized that large OR subfamilies
came to existence through frequent and/or large duplication
events, implying that genes from large OR subfamilies will be
prone to reside in CNV loci. However, our data showed no
obvious correlation between OR subfamily size and averaged
variances of R (Figure S10). This may partly be due to a
confounding factor, namely the reduced sensitivity of microarrays
in detecting CNVs within regions sharing very high sequence
similarity (see additional discussion bellow); such regions are
enriched in the largest OR subfamilies, and our microarrays may
have failed to detect CNVs in these.
As discussed above, our high-resolution data helped to clarify
that CNVs do not randomly affect genes and pseudogenes, and
that for OR genes purifying selection may operate on top of
formation biases. In evolutionary terms, CNVs, which are variants
en route to fixation, have good potential to influence the OR
repertoire size. Here, we have presented evidence for an
abundance of polymorphic gene loss events affecting the most
copy-number variable group of ORs, i.e. a group classified here as
evolutionarily ‘‘young’’. This may point to one possible underlying
mechanism for the well-documented diminution of the human OR
repertoire as it is reflected in the considerably reduced human OR
repertoire size (i.e. 851 ORs) compared with dog and chimpanzee
(,1000 ORs), and with rat and mouse (,1400 ORs) ([5] and
references therein). It should be noted, however, that although
these ORs were herein classified as ‘‘young’’ for simplicity, they do
not necessarily have to represent recent gene duplicates. In
particular, due to the orthology assignments, ORs that underwent
deletion or duplication in the chimpanzee genome are also
classified as ‘‘young’’ in our study. In contrast, the more ‘‘ancient’’
ORs potentially provide a more stable backbone of the olfactory
subgenome, which is less affected by CNVs and also appears to
have an overall positive balance between gains and losses. This
slight enrichment for gains may imply stronger evolutionary
constraints acting on these ORs, as losses are thought to be more
detrimental than gains, and genes under purifying selection are
more biased away from deletions than from duplications [13].
The identification of 9 deletion alleles, encompassing 15 OR
gene loci and present at appreciable frequency, is significant for
studies of olfactory function. Previously, functional OR gene
inactivation alleles, involving SNPs leading to in-frame stop
codons or substitution of conserved amino acids in an otherwise
unmodified OR locus sequence, have been reported [6,37]. Such
alleles were subsequently linked to individual human responses to
specific odorants, using both in-vitro and association study
approaches [12]. However, large deletions have not so far been
reported among the variants used for genetic association studies.
The present identification of a number of unexpectedly frequent
deletion alleles (with deletion allele frequencies of up to 0.6), some
of which encompass several genes from the same OR subfamily,
thus provides additional strong candidates for genetic association
studies of human olfaction. To this end, we have recently initiated
a CNV genotyping experiment using qPCR for the herein
reported deletion I (Table 3) against a Caucasian cohort [40] of
94 subjects, phenotyped for olfactory acuity towards eight
odorants (unpublished). The results were inconclusive, probably
due to the low number of samples and odorants involved. Future
association studies will require larger sample sizes and, ideally, a-
priori in-vitro assessment of ligand specificity for the affected ORs.
Our study also has certain technical limitations. First, while
microarrays represent the most cost-effective method for studying
CNVs at large scale and high resolution, cross-hybridization limits
their specificity and sensitivity in repetitive genomic regions.
Cross-hybridization results in averaging of the signal over several
loci, and is thus more likely to lead to false negative than to false
positive CNV calls when using a stringent cutoff for scoring the
arrays. A second potentially confounding factor is the inter-
individual sequence variability, i.e. SNPs and small indels, that
may affect probe hybridization. Yet, different probes on our arrays
are generally &1 bp apart from each other, there are dozens of
probes for each locus, and the signal is analyzed over all probes
mapping to an OR locus. Thus, inter-individual sequence
variability in specific probes, typically at the level of 1 SNP per
kilobase, is unlikely to considerably affect our CNV calls.
Furthermore, our qPCR results indicate that the false-positive
rate is relatively low in our microarray experiments, as opposed to
a considerable false negative rate, which was expected due to the
stringent cutoff applied for scoring the arrays. Third, the
comparative nature of our analysis may introduce an overestima-
tion of the frequencies of some CNVs, if the reference sample
carries a rare allele. In such cases, the rest of the samples are
expected to show only one type of change – gain or loss, across a
majority of the samples. Importantly, this would not change the
CNV status of the locus (i.e. whether the OR is considered to be
copy-number variable or not), and thus did not affect the main
conclusions of this study. We nevertheless specifically addressed
Olfactory Receptor CNVs
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individual (see Text S1), an analysis that did not considerably
affect our overall CNV counts and did not change the conclusions
of our study. Fourth, a considerable fraction of CNVs may
represent recurrent, rather than common variants emerging from
single mutational events (Table S3). Distinguishing recurrent from
common CNVs coherently will become a challenging task that will
require breakpoint-resolution data, which is currently available
only for few CNVs affecting ORs. Finally, a large portion of CNVs
(62%, Table 1) reported in DGV to intersect with OR loci are not
observed in our study. This is likely to be, in part, attributed to the
relatively low number of samples we analyzed and to false-negative
calls in our study, but also to the fact that for most CNVs listed in
DGV the size-ranges have been overestimated (in this regard, note
the excellent recent survey published in [29]). Furthermore, a
parallel survey of CNVs affecting functional OR loci was
published while the present paper has been under review [41].
In this study, the authors report a statistical analysis of a subset of
CNVs listed in DGV, as well as an experimental validation of
CNVs recorded in DGV, which affect a set of 37 OR loci. In
agreement with our data, they failed to validate 16 out of the 37
CNVs tested, despite using 50 samples of diverse ancestry.
Altogether, these results support the size over-estimation of
previous CNV surveys at low resolution ([29,41]) and stress the
relevance of systematic follow-up studies focusing on CNV subsets.
In conclusion, our results emphasize the importance of carrying
out genome-wide CNV surveys at high resolution. This is
especially important, if one aims to identify events relevant to
association studies, which requires the delineation of CNV event
nature (i.e. deletion/duplication or complex, common or recur-
rent), exact CNV boundaries, and CNV population frequencies.
Thus our study both provides insights into the evolution of the
largest human gene family, and suggests specific targets for
subsequent association studies.
Materials and Methods
High-Resolution Oligonucleotide Tiling Microarray Design
To determine copy-number variation at OR loci genome-wide
and at exon-level resolution, custom high-resolution oligonucleo-
tide tiling microarrays were designed using Nimblegen/Roche
technology. The microarrays contained 71,980 different oligonu-
cleotide probes of length 45–85 bp, adjusted in C+G content to
yield similar optimum hybridization temperatures [22]. Further, to
save experimental costs and make the platform more efficient,
multiplex (4-plex) microarrays were used. We designed the probes
to cover all 851 OR loci represented in the reference genome
(build35), i.e. 388 OR gene loci and 463 OR pseudogene loci
including the respective 59-regions (i.e., 10–20 kb upstream of
genes and pseudogenes) and 39-regions (2 kb downstream of
genes/pseudogenes; depiction of probe locations for an example
OR locus are presented in Figure S1). Before assigning
oligonucleotide probes to loci, we separated the frequently
partially overlapping OR loci within genomic gene clusters to
avoid assigning probes to multiple ORs loci. Overlapping loci
were separated according to the orientation of the OR open
reading frames they contained. If both ORs were oriented 59 to 59
or 39 to 39, the region between them was divided equally between
the 2 loci. However, if the orientation was 59 to 39, the separation
was such that 15% of the region (not exceeding 2 kb) was assigned
to the 39 of one of the OR loci, and 85% were assigned to the 59 of
the other OR locus. Genomic coordinates of OR genes and
pseudogenes were obtained from the HORDE database (http://
bip.weizmann.ac.il/HORDE/).
A median genomic distance between interrogated oligonucleo-
tides of 148 bp was used on the arrays, a density expected to allow
the identification of breakpoints of CNVs at ,500 bp resolution
[23]. Our custom microarray design approach focused on optimum
oligonucleotide probes and excluded highly repetitive regions. In
particular, (i) oligonucleotides of length 85 bp were extracted from
the human reference genome; each oligo was truncated according to
its GC content [22] and subsequently aligned against the genome
using BLASTN (ncbi); (ii) the array design was initiated by picking
oligonucleotides with an offset of 148 bp, thereby considering oligos
only if these did not reveal an additional hit to the reference genome
at a sequence identity cutoff S of 90%, indicating probe redundancy.
(iii) If less than the average number of probes per gene/pseudogene
locus were picked in the previous step, additional oligos were added
to the array, initially by changing the offset to 74 bp, and then by
incrementally increasing S from 91% to 99%. The median number
of probes per locus was 86; in some instances, i.e. in case of highly
similar (paralogous) regions in the genome, the minimum number of
independentprobeswas20foreachORlocus(asanexception,three
small OR pseudogene loci were included in the set, having 14, 15,
and 16 independent probes, respectively). In 3 cases, to reach a
minimum of 20independent probemeasurementsper OR locus and
facilitate robust CNV detection, duplicate probes were included in
the set (as for all other probes used, these duplicates matched
perfectly to the target locus only).
DNA Samples
Twenty-fivegenomicDNAsamples(DNAfromcelllinesobtained
from Coriell; mostly HapMap samples) were used in this study,
covering three populations (European, Asian, Nigeria/Yoruba), as
follows:
NA12003, NA12004, NA12005, NA12006, NA12246,
NA12248, NA12865, NA10851, NA11997- Europeans (CEPH);
NA15510- presumably European [14];
NA18611- Asian (Chinese origin);
NA18945, NA18946, NA18972- Asians (Japanese origin);
NA18504, NA18508, NA18856, NA19103, NA19141,
NA18501, NA18502, NA18505, NA18506, NA19128,
NA19154- Africans (with origin from Nigeria; Yoruba).
High-Resolution Oligonucleotide Tiling Microarray Analysis
We interrogated genomic DNA from pairs of two individuals
(one labeled with Cy3, one with Cy5, measured in different
channels) by following the high-resolution comparative genome
hybridization protocol previously described [22]. In our analysis
pipeline, Cy3 and Cy5 labeled DNA was independently analyzed
– that is, two distinct ‘intensity-measurements’ were retrieved from
each panel of the novel Nimblegen multiplex platform (eight
distinct measurements per 4-plex microarray experiment; each
panel carried 71,980 probes). Quantile normalization (i.e., the
algorithm normalize.quantiles from www.bioconductor.org) was
used to normalize all channel measurements simultaneously,
yielding overall identical intensity distributions for each channel
across all experiments. Subsequently, for each oligonucleotide
probe on the array, log2-ratios r were obtained by relating
normalized intensities i for each probe to median normalized
probe intensities calculated across three replicates c1, c2, and c3 of a
designated control individual (NA19154):
r~log2i{log2median c1,c2,c3 ðÞ :
For NA12246, NA15510, NA19103, and NA19141 the
microarray experiments were performed in replicate, each
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ratios r obtained from the replicates were used for further analysis.
CNVs affecting OR loci were called using the following approach:
we calculated R as the median r of all probes that unambiguously
map to an OR locus and scored loci as being affected by a CNV if
abs(R) is greater or equal to a cutoff C=0.18. At this cutoff value, an
independent additional technical replicate of NA19541 yielded only
2 predicted CNVs (false positives) affecting OR genes or pseudo-
genes; this suggests a false positive rate of ,4% for our CNV calls, as
the mean number of such CNVs in otherindividuals was 54 (median
53). Since C represents a conservative cutoff for R-measures that also
led us to overlook some true CNVs (see below), we decided to apply
raw R-values, rather than copy-number calls, for measuring some of
the correlations presented below (e.g. such presented in Figures 3,
S3, and S6).
Calculation of Average Number of CNV Events/Sample
Following the scoring of the array data according to cutoff C (see
above), microarray intensities were converted to discrete values of
1, 21 and 0, representing gains, losses and neutral values
respectively. For each sample we counted the total number of
CNV events (gains or losses). Next we calculated the average of the
total number of events per sample found in 24 individuals.
Statistical Calculations
Pearson correlations and respective P-values were calculated using
Wessa, P. (2008), Free Statistics Software, version 1.1.23-r1, at http://
www.wessa.net/. Chi-square tests and contingencytables probabilities
were calculated using http://www.physics.csbsju.edu/stats.
Quantitative PCR
Quantitative PCR (qPCR) was carried out using Absolute Blue
SYBR Green Rox Mix (ABgene) on a Roche LightCycler 480.
Concentrations of the DNA samples were measured using a
NanoDrop 1000 spectrophotometer. The samples were diluted to
1n g / ml stock. Prior to each experiment, 8 ml of every sample was
dispensed into the 96 well qPCR plate by Biomek 3000 robot, in
duplicates, and dried over-night. The reactions were carried out in a
96-well plate in 10 ml volume, containing 5 ml of Blue-SYBR-Green
mix, 0.5 mM of each primer and 8 ng of genomic DNA. The
following thermocycling program was used: Enzyme activation,
95uC, 15 min; 40 cycles of denaturation at 95uC, 15 sec, and
annealing & extension at 60 C, 1 min. After amplification the
temperature was slowly raised and fluorescence was continuously
monitored to produce melting curves of every product, so as to verify
product specificity. Reactions that indicated more than one peak in
the melting curves, were removed from further analysis. All qPCR
results are summarized in Table S1.
The qPCR results were normalized using qPCR results of the
regulator of calcineurin 1 (RCAN1) gene (previously Down
Syndrome Critical Region 1 gene (DSCR1)), presumed not to
vary in copy number in normal individuals[24,25]. For compar-
isons between microarray and qPCR results we performed a
further normalization by log scale subtraction of the value for the
designated reference sample NA19154. The 56 most variable OR
loci were selected based on the variance of qPCR results, such that
25 most variable blocks of OR loci were represented. ORs that did
not show gains or losses, but revealed a variance in qPCR results
.0.15, were considered as additional CNVs.
Standard PCR and Gel Electrophoresis
Polymerase chain reaction (PCR) amplification was performed
in 10 ml volume, using Qiagen HotStart Taq polymerase enzyme,
and standard supplier protocol. The following thermocycling
program was used: enzyme activation, 95uC, 15 min; followed by
45 cycles of denaturation at 95uC, 15 sec, annealing at 58uC,
30 sec, and extension at 72 C, 1 min. Products were analyzed by
gel electrophoresis, in 2% agarose gel with 100 bp marker.
Primer Design
Primers were designed with Primer3 (http://fokker.wi.mit.edu/
primer3/input.htm) software using the following parameters:
melting temperatures (Tm) between 56 and 60uC, GC-content
between 30% and 70% and length from 18 to 28 bp. Uniqueness
of primers and amplicons was checked using BLAT and in-silico-
PCR against the hg18 reference assembly (available at http://
genome.ucsc.edu) [26]. In the case of qPCR, all primers were
designed to amplify 100–200 bp segments. In cases where
automatic design failed to produce specific primers we designed
them manually using sequence alignments. All primers were
adjusted for the thermodynamical properties used in Primer3, and
checked for uniqueness as described above.
Computational Identification of CNV Breakpoints
Affecting OR Loci
CNV breakpoints affecting OR loci were identified using two
complementary approaches. (i) Breakpoints of CNVs were
predicted from the high-resolution microarray data using the
BreakPtr algorithm [23]. Namely, although most CNV breakpoints
likely occur outside OR gene/pseudogene loci, we tested whether
some CNVs disrupt the loci targeted in this study. We therefore
applied the default parameters of BreakPtr (‘core parameterization’
[23]) to fine-map CNV breakpoints. We conservatively considered
breakpoint-assignments within a locus as robust, if a minimum of 5
probes were present on either side of the breakpoint junction and
supported the predicted dosage change [23] (only such robust
breakpoint assignments were reported by us). (ii) Deletion
breakpoints were identified computationally through analyzing
genomic clones deposited in Genbank that are not included in the
current reference genome. Namely, fosmids were selected from
Genbank by using the keywords ‘‘fosmid’’ and ‘‘complete
sequence’’. This library, which contained 1807 clones, was
screened specifically for OR genes using the TBLASTN (ncbi)
algorithm. Altogether, we found 30 fosmids that contained at least
one full-length OR gene. These 30 fosmids were subsequently
aligned to the human genome in 20 kb fragments using the BLAT
algorithm [26]. Fragments that aligned to regions of lengths
different from 20 kb were suspected to contain deletions or
insertions, and were inspected manually. The clone AC208786
was found to contain the OR8U8 and OR8U9 genes, both of which
are not present in the reference genome. AC193144 contains
deletion VI, and AC210900 contains deletion I, listed in Table 3.
OR9G9 was found on chr11 of the Celera assembly, and also on
clone AC212901. The Celera assembly was mined using
methodologies described in [27]. To identify deleted ORs from
Craig Venter’s genome [28] we analyzed table ‘‘HuRef_homozy-
gous_indels_inversion_gff.txt’’ from the supplementary material of
[28].
Orthology Assignments
We identified OR loci with a one-to-one ortholog in the
chimpanzee genome by comparing OR gene/pseudogene coding
regions in a pair-wise and bidirectional fashion between human
and chimpanzee using BLAST [26]. OR loci were assumed to
have a one-to-one ortholog in chimpanzee if, and only if, a
corresponding bi-directional (i.e. reciprocal) best hit was found in
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bi-directional best hits was 98%.
Determination of Ancestral Alleles
Ancestral alleles for deletions were determined based on
bidirectional best hits between the whole deletion region and the
individual OR genes versus the Pan troglodyes reference assembly
(March 2006, Build 2.1). For that purpose, orthologous regions
between human and chimpanzee were aligned using MEGA-
BLAST (ncbi) and BLAT. For the OR8U1 locus we also used a
sequence from Celera’s latest human genome assembly (R27c).
Our searches usually revealed syntenic and highly identical
orthologous regions (coverage.98% and maximum identi-
ty.96%), except for OR2T10 (coverage=82% and maximum
identity=80%), for which the region coincides with a gap in the
chimpanzee genome.
Supporting Information
Figure S1 Example of array design in specific OR region. Array
probes are depicted in red, OR territory and open reading frame
in blue (59 and 39 are marked accordingly),and repeat regions are
in black. The depicted image is based on a UCSC browser
representation of an exemplary region (OR4C11). Microarrays
contained 71,980 different oligonucleotide probes of length 45–
85 bp. We designed the probes to cover all 851 OR loci
represented in the reference genome (build35), including the
respective 59-regions (10220 kb upstream), and the 39-regions
(2 kb downstream). The median genomic distance between
interrogated oligonucleotides was 148 bp; probes in highly
repetitive regions were excluded. Note that due to the resolution,
in some cases overlapping probes may appear as thick red lines.
Found at: doi:10.1371/journal.pgen.1000249.s001 (0.36 MB TIF)
Figure S2 Variance of experimental measures in qPCR and
microarray experiments. Mean variance of the qPCR data (upper
panel) and the corresponding measure R from the arrays (median
normalized log2-ratio of all probes that unambiguously map to an
OR locus; here ‘‘array intensity’’) for 122 OR loci (lower panel).
The red dotted line indicates a conservative variance cutoff of 0.15
for qPCR results (ORs with qPCR measures beyond this cutoff
presumably represent CNVs and are given in Table 3).
Found at: doi:10.1371/journal.pgen.1000249.s002 (0.83 MB
DOC)
Figure S3 Correlation of qPCR and microarray experiments. A)
Correlation of variance in qPCR and array measures R. Each data
point represents variance measures for a single OR locus. The
correlation coefficient measured for ORs affected by CNVs is
C=0.37 (Pvalue=0.005), and C=0.02 (Pvalue=0.4; not signif-
icant) for unaffected ORs. Red dots represent ORs affected by
CNVs called with our microarrays; blue dots: unaffected ORs. B)
Correlation between normalized qPCR values and array measures
R. Each data dot indicates a single individual and its measured
values in both qPCR and array experiments for a single OR locus.
Correlation for ORs affected by CNVs is C=20.43 (Pva-
lue=10250), and for unaffected ORs C=20.08 (Pvalue=0.001).
Linear regression fits of each dataset (CNVs and unaffected ORs)
are indicated with red and blue dashed lines, respectively.
Found at: doi:10.1371/journal.pgen.1000249.s003 (0.72 MB TIF)
Figure S4 Distribution of qPCR variance measures for 122
ORs. A conservative cutoff of 0.15, likely corresponding to a
CNV, is indicated by a red dashed line.
Found at: doi:10.1371/journal.pgen.1000249.s004 (0.57 MB TIF)
Figure S5 Detection of a homozygous deletion of OR4C11 in 2
samples. qPCR amplification curves and PCR gel product for the
OR4C11 locus. Samples NA12003, NA12004, NA12246 and
NA12248 are labeled 1–4, respectively. Panel I: qPCR amplifi-
cation curves for OR4C11 in 23 individuals. Black arrows indicate
curves corresponding to a negative control (BL); red arrows
indicate samples (1,3) with a presumed homozygous deletion.
Panel II: Standard PCR results of OR4C11 in the 4 samples,
analyzed by gel electrophoresis (see Methods)
Found at: doi:10.1371/journal.pgen.1000249.s005 (0.95 MB TIF)
Figure S6 CNVs affecting the OR repertoire are multi-locus and
associated with telomeres/centromeres. A) Correlation between
meanvariances inmicroarrayexperiments (i.e. R-measures)for each
pair of adjacent ORs in the same cluster. The variance for each OR
locus (OR1) is plotted against the variance of the neighboring OR
locus (OR2). Red and blue indicate copy-number variable and non-
variable ORs, respectively. The variability status (CNV, non-CNV)
was defined according to OR1. Correlation for ORs affected by
CNVs is C=0.8 (Pvalue=10218) and for non-variable ORs
C=0.18 (Pvalue=1026). Linear regression fits of each dataset are
shownasdashed lines. B)Distance ofeachOR locus to telomereand
centromere. Correlation for ORs affected by CNVs is C=20.17
(Pvalue=0.003), and for non-variable ORs C=0.03 (Pvalue=0.19;
not significant). Linear regression fits of each dataset are shown as
dashed lines. C. Pearson correlation of cross-individual patterns
based on R between two consecutives variable ORs (see text). For
this analysis we chose 140 ORs, from 36 OR clusters, and used the
criteria that at least2 consecutive ORs, of the same cluster, had to be
variable.
Found at: doi:10.1371/journal.pgen.1000249.s006 (1.59 MB TIF)
Figure S7 Distribution of CNV blocks sizes. CNV blocks were
defined as adjacent variable ORs (based on R-measures), within
the same genomic cluster. Bars show the distribution of the
number of ORs in CNV blocks, some of which likely represent
large CNVs (see text). Numbers on top of a bar indicate number of
CNV blocks for a relevant size.
Found at: doi:10.1371/journal.pgen.1000249.s007 (0.27 MB TIF)
Figure S8 Overlap between pairs of tandemly oriented segmen-
tal duplications (SDs) and genomic OR clusters. Bars indicate
average number of SD pairs that overlap with OR clusters.
Clusters were classified into 3 groups: ‘‘CNV’’ - clusters for which
each OR locus (including genes/pseudogenes) in the cluster was
found to be affected by a CNV at some point during our analysis
OR-specific, ‘‘NV’’ - non variable clusters for which no copy-
number variation was observed, and ‘‘mixed CNV/NV’’ - clusters
that encompasses both copy-number variable and non-variable
OR loci. Orange bars represent data normalized for cluster size,
whereas yellow bars depict results without normalization. Error
bars indicate 95% confidence interval, ‘‘n’’ is the number of
clusters in each group, ‘‘ORs/cluster’’ indicates average number of
ORs in clusters. Note the significant enrichment of segmental
duplication pairs in the ‘‘CNV’’-group compared to the ‘‘NV’’-
group (P-values 0.007 and 0.003).
Found at: doi:10.1371/journal.pgen.1000249.s008 (0.47 MB TIF)
Figure S9 NAHR affecting the OR8U8/OR8U9 ancestral locus
leads to formation of the OR8U1 fusion gene. Schematic
representation of the NAHR event in which the two genes
OR8U8 and OR8U9 led to the formation of the fusion gene
OR8U1. Arrows represent locations of the allele-specific primers we
used, demonstrating that both alleles are commonly present in the
human population.The bottom panel showsthe sequence alignment
of the three genes, OR8U8, OR8U9, and OR8U1. Note the
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O R 8 U 8a n dO R 8 U 1a tt h e5 9 region (bases 472–590).
Found at: doi:10.1371/journal.pgen.1000249.s009 (1.35 MB TIF)
Figure S10 Correlation of OR copy-number variability with
paralog-similarity, but not with OR subfamily size. OR subfamily
assignments were based on the HORDE database (http://bip.
weizmann.ac.il/HORDE/). Each circle represents an OR sub-
family of certain size, as indicated by circle size and color
(according to the scale on the right). Numbers in parentheses
indicate numbers of subfamilies of a given size, e.g. there are 52
subfamilies with 2 OR members. The largest subfamily with 85
members is subfamily 7E. Average best-hit % identity was
calculated as the average of all % identities of each subfamily
member with its closest OR. Average subfamily variance was
calculated as the average R-based variance of all ORs in a
subfamily. (A linear regression fit was calculated for subfamilies
with 2 members.
Found at: doi:10.1371/journal.pgen.1000249.s010 (0.78 MB
DOC)
Table S1 Normalized qPCR Cp values for 122 OR loci.
Quantitative PCR (qPCR) data of 122 ORs, measured in 22
individuals. The qPCR values are normalized relative to the
RCAN1 gene. NT: -Not Tested-; DEL: reactions consistently
failed in both duplicates (in at least two independent experiments),
thus indicating a homozygous deletion of the locus.
Found at: doi:10.1371/journal.pgen.1000249.s011 (0.06 MB XLS)
Table S2 Coordinates and normalized microarray measures R
for all OR loci. Mean normalized relative intensities (i.e. the
measure R) for 851 OR gene and pseudogene loci, are given as
detected using custom high-resolution oligonucleotide tiling
microarrays. Genomic coordinates for each locus are indicated.
OR loci with R.0.18 were called as gains, and with R,0.18 as
losses, respectively, relative to the designated reference individual
NA19154.
Found at: doi:10.1371/journal.pgen.1000249.s012 (0.48 MB XLS)
Table S3 *Evidence for both a gain and a loss observed in a
single territory and sample. **This CNV likely corresponds to a
deletion with breakpoint junctions fusing OR51A2 and OR51A4,
previously seen by us using another method (Korbel et al. 2007,
Science 318:420-6). This deletion results in a new gene with a
coding region identical to OR51A4 and upstream regions from
OR51A2, which is combined with a loss of the OR51A2 coding
region. ***Breakpoints within a locus were called if, and only if, at
least 5 probes were on either side of the breakpoint junction,
supporting the predicted dosage change. ****For eight loci
(OR2T11, OR4S1, OR4N2, OR11H3P, OR10H2, OR7E125P,
OR7E96P, and OR13J1) at least two breakpoints intersecting with
the locus were predicted with a distance of more than 1000 bp
apart from each other. This suggests that in those loci CNVs may
have been formed recurrently, as the expected resolution of the
calls is ,500 bp (see Methods).
Found at: doi:10.1371/journal.pgen.1000249.s013 (0.04 MB XLS)
Text S1 Supplementary analysis.
Found at: doi:10.1371/journal.pgen.1000249.s014 (0.04 MB
DOC)
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